Hematologic Malignancies
Conference Coverage
Home care for bortezomib safe and reduces hospital visits in myeloma patients
News
Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patients
News
Beat AML: Precision medicine strategy feasible, superior to SOC for AML
"The study is changing significantly the way we look at treating patients with AML, showing that precision medicine ... can improve short- and...
Conference Coverage
Novel agents hold promise for frontline AML treatment
Conference Coverage
Novel treatments under study for chronic graft-versus-host disease in allo-HCT
Conference Coverage
Final ASCEND study data: Acalabrutinib beat standard of care for r/r CLL
News
Socioeconomic factors affect survival of multiple myeloma patients
Article
Are oncologists ready to confront a second wave of COVID-19?
News
ESMO offers new clinical practice guideline for CLL
Conference Coverage
Can AML patients be too old for cell transplantation?